474 related articles for article (PubMed ID: 30484140)
1. Financial Impact of Alternative Pricing Benchmarks for Physician-Dispensed Drugs in the California Workers' Compensation System.
Wilson L; Turkistani F; Tran DM; Huang W; Lin TK
Appl Health Econ Health Policy; 2019 Apr; 17(2):231-242. PubMed ID: 30484140
[TBL] [Abstract][Full Text] [Related]
2. The impact of alternative pricing methods for drugs in California Workers' Compensation System: Fee-schedule pricing.
Wilson L; Turkistani FA; Huang W; Tran DM; Lin TK
PLoS One; 2018; 13(5):e0197449. PubMed ID: 29799850
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical pricing benchmarks: governmental versus private sector.
Turkistani F; Sawad AB
J Comp Eff Res; 2020 Oct; 9(15):1091-1100. PubMed ID: 33052057
[No Abstract] [Full Text] [Related]
4. Utilization, Cost, and Pricing Scheme of Compounded Medications for Public Health System Patients: The California Workers' Compensation System, 2011-2013.
Lin TK; Shoair OA; Tran D; Wilson L
J Manag Care Spec Pharm; 2019 Jul; 25(7):743-751. PubMed ID: 31232208
[TBL] [Abstract][Full Text] [Related]
5. Use and Costs of Medical Foods and Convenience-Packaged Drugs in the California Workers' Compensation System.
Lin TK; Wilson L
J Manag Care Spec Pharm; 2018 Aug; 24(8):819-833. PubMed ID: 30058988
[TBL] [Abstract][Full Text] [Related]
6. Repackaged pharmaceuticals in the California workers' compensation system: from distribution and pricing options to physician and retail dispensing.
Gitlin M; Wilson L
Am J Ind Med; 2007 Apr; 50(4):303-15. PubMed ID: 17370319
[TBL] [Abstract][Full Text] [Related]
7. New workers' compensation legislation: expected pharmaceutical cost savings.
Wilson L; Gitlin M
Am J Ind Med; 2005 Oct; 48(4):239-48. PubMed ID: 16142746
[TBL] [Abstract][Full Text] [Related]
8. Physician and Patient Adjustment to Reference Pricing for Drugs.
Robinson JC; Whaley C; Brown TT; Dhruva SS
JAMA Netw Open; 2020 Feb; 3(2):e1920544. PubMed ID: 32022881
[TBL] [Abstract][Full Text] [Related]
9. AMCP Guide to Pharmaceutical Payment Methods, 2009 Update (Version 2.0).
Academy of Managed Care Pharmacy
J Manag Care Pharm; 2009 Aug; 15(6 Suppl A):S3-57, quiz S58-61. PubMed ID: 19678720
[TBL] [Abstract][Full Text] [Related]
10. Trends in Prices of Drugs Used to Treat Metastatic Non-Small Cell Lung Cancer in the US From 2015 to 2020.
Desai A; Scheckel C; Jensen CJ; Orme J; Williams C; Shah N; Leventakos K; Adjei AA
JAMA Netw Open; 2022 Jan; 5(1):e2144923. PubMed ID: 35076701
[TBL] [Abstract][Full Text] [Related]
11. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
Kesselheim AS; Avorn J; Sarpatwari A
JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
[TBL] [Abstract][Full Text] [Related]
12. Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.
Raimond VC; Feldman WB; Rome BN; Kesselheim AS
Milbank Q; 2021 Mar; 99(1):240-272. PubMed ID: 33751664
[TBL] [Abstract][Full Text] [Related]
13. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.
Balkhi B; Seoane-Vazquez E; Rodriguez-Monguio R
Int J Technol Assess Health Care; 2016 Jan; 32(6):385-392. PubMed ID: 28065194
[TBL] [Abstract][Full Text] [Related]
14. Effects of provider networks on health care costs for workers with short-term injuries.
Baldwin ML; Johnson WG; Marcus SC
Med Care; 2002 Aug; 40(8):686-95. PubMed ID: 12187182
[TBL] [Abstract][Full Text] [Related]
15. Do generics offer significant savings to the UK National Health Service?
Kanavos P
Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472
[TBL] [Abstract][Full Text] [Related]
16. Changes in Drug List Prices and Amounts Paid by Patients and Insurers.
Yang EJ; Galan E; Thombley R; Lin A; Seo J; Tseng CW; Resneck JS; Bach PB; Dudley RA
JAMA Netw Open; 2020 Dec; 3(12):e2028510. PubMed ID: 33295971
[TBL] [Abstract][Full Text] [Related]
17. A study of the additional costs of dispensing workers' compensation prescriptions.
Schafermeyer KW
Res Social Adm Pharm; 2007 Mar; 3(1):123-36. PubMed ID: 17350561
[TBL] [Abstract][Full Text] [Related]
18. Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019.
Clemans-Cope L; Epstein M; Banthin J; Kesselheim AS; Hwang TJ
JAMA Health Forum; 2023 Jan; 4(1):e225012. PubMed ID: 36637815
[TBL] [Abstract][Full Text] [Related]
19. Fewer workers' compensation claims and lower claim costs if employers with high injury rates achieved the rates of their safer peers.
Wuellner SE; Bonauto DK
J Safety Res; 2019 Sep; 70():97-103. PubMed ID: 31848014
[TBL] [Abstract][Full Text] [Related]
20. Drug pricing and value in oncology.
Danzon PM; Taylor E
Oncologist; 2010; 15 Suppl 1():24-31. PubMed ID: 20237214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
